Canmab 150mg Injection
By Canmab
Rx
1ml Injection in a Vial

Composition
Trastuzumab(150mg)

Manufacturer - Biocon
20th KM, Hosur Road, Electronic City, Bangalore, India - 560 100

Expires on or after
September, 2026

liver
There is limited information regarding the use of Canmab 150mg Injection in patients with liver disease. It is advised to consult your doctor if you have any liver-related issues before using this medication. Your doctor can provide you with proper guidance on the safety of using Canmab 150mg Injection in case of liver problems.

kidney
Canmab 150mg Injection is likely safe for patients with kidney disease. Existing data indicates that adjusting the dose may not be necessary. Consult your doctor for guidance.

alcohol
Canmab 150mg Injection may lead to increased drowsiness if combined with alcohol.

driving
While taking Canmab 150mg Injection, avoid driving if you notice symptoms impacting your focus and reaction time. It is uncertain if this medication affects driving abilities.

pregnancy
Canmab 150mg Injection is not safe during pregnancy due to known risks to the baby. However, in rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Canmab 150mg Injection may not be safe during breastfeeding as it could pass into breastmilk and harm the baby. It is advisable to consult a doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | - |
Action Class | HER2/neu (ErbB2) Inhibitor- Monoclonal antibody |
₹23883.76
₹25883.76
7.73% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024